Drug Trial Radar · NCT03483961
Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults
Last checked: Nov 20, 2026Latest source record: Jul 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
445
Actual
Start
Apr 18, 2018
Primary completion
Sep 14, 2020
Study completion Sep 21, 2020
Sponsor
- Lead sponsor
- Bavarian NordicIndustry
- Sponsor type
- Industry
- Collaborators
- Emergent BioSolutions
- First posted
- Mar 30, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this Phase 2 trial is to evaluate the immune response to and safety profile of various doses/formulations/and schedules of administration of PXVX0317 in healthy adults. Primary Objective: To assess the immune response to the vaccine Secondary Objectives: To assess the kinetics of the immune response to different doses/formulations/schedules To assess the persistence of immune responses to different doses/formulations/schedules To assess the effect of a booster dose of the vaccine Safety Objective: To assess local and systemic reactions to the vaccine and to describe the safety profile of the vaccine
Conditions
- Chikungunya Virus Infection
Interventions
CHIKV VLP/unadjuvantedBiological
Vaccine consists of virus-like particles of chikungunya virus antigens
CHIKV VLP/adjuvantedBiological
Adjuvanted formulation includes Alhydrogel
PlaceboBiological
Placebo is vaccine diluent alone
Primary outcomes
What the sponsor says the trial is designed to measure.
- Anti-CHIKV Neutralizing Antibody Geometric Mean Titer 28 Days After the Last Injection for Groups 2-8.Time frame: Day 57 (from Day 1 vaccination), 28 days after the last injection.
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Johnson County Clin-Trials
Lenexa, Kansas
The Center for Pharmaceutical Research
Kansas City, Missouri
Advanced Clinical Research
West Jordan, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.